GSKNYSEPharmaceutical PreparationsAlso trades as GLAXF

GSK plc

Financials through fiscal 2025, year ended Dec 31, 2025

$49.46−0.05 (-0.10%)

Close on Oct 19, 2026

Fundamental chart

Pick a measure to chart its full history

£32.67BFY2025, +3.2% a year since FY2015

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is GSK.

Revenue growth4.1% · median 4.4%

Gross margin72.4% · median 71.6%

Net margin17.5% · median 6.8%

Advertisement
300 × 250